Recommendations for interventional pulmonology during COVID-19 outbreak: a consensus statement from the Portuguese

F Guedes1, J P Boléo-Tomé2, L V Rodrigues3

  • 1Centro Hospitalar do Porto (CHP), Hospital Geral de Santo António (HGSA), Unidade de Broncologia, Serviço de Pneumologia, Porto, Portugal; Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Porto, Portugal; Centro de Estudos de Ciência Animal (CECA), Instituto de Ciências, Tecnologias e Agroambiente (ICETA) da Universidade do Porto, Praça Gomes Teixeira, Apartado 55142, 4051-401, Porto, Portugal.

Pulmonology
|September 2, 2020
PubMed

Insights

Healthcare workers performing bronchoscopy face high COVID-19 infection risks. This guide offers recommendations for safe interventional pulmonology procedures during the pandemic until vaccines are available.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, spreads rapidly via respiratory droplets.
  • Healthcare workers are at high risk of infection, particularly during aerosol-generating procedures like bronchoscopy.
  • Existing recommendations require updates to address the ongoing presence of SARS-CoV-2 in the community.

Purpose of the Study:

  • To provide guidance for interventional pulmonology practices during the COVID-19 pandemic.
  • To outline safe and efficient protocols for performing bronchoscopy and pleural procedures.
  • To address the long-term management of COVID-19 in clinical settings.

Main Methods:

  • Review of current literature and expert consensus on infection control.
  • Adaptation of standard bronchoscopy and pleural procedure techniques.
  • Development of safety protocols for patients and healthcare personnel.

Main Results:

  • Bronchoscopy and pleural procedures carry significant risks of SARS-CoV-2 transmission.
  • Modified procedures are necessary to minimize droplet spread and protect staff.
  • Recommendations focus on safety measures applicable until widespread vaccination or effective treatments are available.

Conclusions:

  • Interventional pulmonology requires adapted procedures to ensure safety during the COVID-19 pandemic.
  • Continuous evaluation and updating of safety protocols are essential.
  • Safe performance of bronchoscopy and pleural procedures is achievable with appropriate precautions.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...